Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil for prevention of postoperative cognitive and psychological dysfunction after sleeve gastrectomy
IRCT20141009019470N76Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of modafinil in post-operative cognitive decline (POCD), anxiety disorder and major depressive disorder (MDD) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Cognitive problems, Depression and 1 more. Started Sep 2018; status: completed.
02
Drugs
modafinil
03
Conditions
post-operative cognitive decline (POCD)anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20141009019470N76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N76.